Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. As previously disclosed, on May 8, 2025, Accelerate Diagnostics, Inc., a Delaware corporation (the “ Company ”), and
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1 Asset Purchase Agreement, dated May 30, 2025, by and between Accelerate Diagnos